(S)-Benzyl 2-((S)-2-(tert-butoxycarbonylamino)-4-methylpentanamido)-3-phenylpropanoate

Intermediate for Carfilzomib. Carfilzomib (trade name: Kyprolis) is an anti-cancer drug acting as a selective proteasome inhibitor. Carfilzomib has been approved by the U.S Food and Drug Administration on July 20, 2012.

Specifications

Product Name:                  (S)-Benzyl 2-((S)-2-(tert-butoxycarbonylamino)-4-methylpentanamido)-3-phenylpropanoate

Synonyms:                         N/A

CAS Number:                     70637-26-2

Molecular Weight:            468.5918

Molecular Formula:          C27H36N2O5

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               CC(C[C@@H](C(=O)N[C@H](C(=O)OCc1ccccc1)Cc1ccccc1)NC(=O)OC(C)(C)C)C

(S)-Benzyl 2-((S)-2-(tert-butoxycarbonylamino)-4-methylpentanamido)-3-phenylpropanoate

  • $1,200.00
  • Ex Tax: $1,200.00

Available Options